Mesoblast (MESO) Invested Capital (2015 - 2025)

Mesoblast (MESO) has reported Invested Capital for 9 consecutive years, with $126.9 million the latest figure, recorded in Q4 2025.

• Quarterly Invested Capital rose 6.63% year-over-year to $126.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $482.1 million (up 5.29% YoY) and the FY2025 annual result came in at $121.9 million, up 6.6% from the prior year.
• Invested Capital improved to $126.9 million in Q4 2025 per MESO's latest filing, from $121.9 million in the prior quarter.
• Over the last five years, Invested Capital for MESO reached as high as $126.9 million in Q4 2025 and fell as low as $30.0 million in Q4 2022.
• A 5-year average of $93.9 million and a median of $101.5 million in 2022 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2022 — Invested Capital tumbled 65.33% — and 2023, when it surged 285.87%.
• Year by year, Invested Capital stood at $86.5 million in 2021, then slumped by 65.33% to $30.0 million in 2022, then jumped by 285.87% to $115.8 million in 2023, then gained by 2.78% to $119.0 million in 2024, then increased by 6.63% to $126.9 million in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered $126.9 million, $121.9 million, and $119.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.